{"transactions":[{"id":705663,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:01:00.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026."}],"balance_after":78000,"derivative":{"exercise_price":4.9,"exercise_date":"2026-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001238705-26-000007","document":"wk-form4_1784577657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000123870526000007/wk-form4_1784577657.xml","form_type":"4"}},{"id":825154,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-03-30T21:29:06.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":37749,"price":6.11,"value":230646.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted to the Reporting Person as a fully vested stock award under the Issuer's 2021 Stock Incentive Plan in partial satisfaction of the 2025 bonus payment to the Reporting Person in lieu of cash, at the Reporting Person's request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split."}],"balance_after":118549,"source":{"system":"sec-edgar","filing":"0001238705-26-000005","document":"wk-form4_1774901174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000123870526000005/wk-form4_1774901174.xml","form_type":"4"}},{"id":1157239,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:07:10.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025."}],"balance_after":700000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001567264-25-000028","document":"wk-form4_1746562022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000156726425000028/wk-form4_1746562022.xml","form_type":"4"}},{"id":1588895,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:01:16.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":33574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested 100% on March 6, 2024."}],"balance_after":33574,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":33574},"source":{"system":"sec-edgar","filing":"0001213900-24-020830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000121390024020830/ownership.xml","form_type":"4"}},{"id":1588894,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29478,"kind":"person","name":"BENDER LEWIS H","position":1,"cik":"0001238705","reported_name":"BENDER LEWIS H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-03-07T23:01:16.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":464805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024."}],"balance_after":464805,"derivative":{"exercise_price":5.19,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":464805},"source":{"system":"sec-edgar","filing":"0001213900-24-020830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238705/000121390024020830/ownership.xml","form_type":"4"}}]}